Paulo Fontoura

Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis

Stephen L. Hauser, Amit Bar‐Or, Gavin Giovannoni et al. · New England Journal of Medicine · 2016 · 1.9K citations · Full text

Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis

Xavier Montalbán, Stephen L. Hauser, Ludwig Kappos et al. · New England Journal of Medicine · 2016 · 1.8K citations · Full text

<i>SMN2</i> splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy

Nikolai A. Naryshkin, Marla Weetall, Amal Dakka et al. · Science · 2014 · 517 citations

Genetics, Molecular Biology, Therapeutics +21

Treatment of Autoimmune Neuroinflammation with a Synthetic Tryptophan Metabolite

Michael Platten, Peggy P. Ho, Sawsan Youssef et al. · Science · 2005 · 411 citations

T-regulatory Cell, Immunology, Immune Regulation +21

Risdiplam in Type 1 Spinal Muscular Atrophy

Giovanni Baranello, Basil T. Darras, John Day et al. · New England Journal of Medicine · 2021 · 383 citations · Full text